5,677 Astera Labs, Inc. $ALAB Shares Sold by Taylor Frigon Capital Management LLC

Taylor Frigon Capital Management LLC decreased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 42.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,609 shares of the company’s stock after selling 5,677 shares during the period. Astera Labs makes up 1.4% of Taylor Frigon Capital Management LLC’s holdings, making the stock its 26th biggest holding. Taylor Frigon Capital Management LLC’s holdings in Astera Labs were worth $2,709,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Greenleaf Trust raised its position in shares of Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after acquiring an additional 36 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in shares of Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after purchasing an additional 41 shares during the period. Integrated Advisors Network LLC boosted its position in shares of Astera Labs by 4.8% during the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after purchasing an additional 45 shares in the last quarter. Glenmede Trust Co. NA boosted its position in shares of Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares in the last quarter. Finally, Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs during the 2nd quarter valued at about $25,000. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 408,558 shares of company stock valued at $127,306,034 in the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

Astera Labs stock opened at $257.16 on Friday. The stock has a market cap of $44.61 billion, a PE ratio of 127.31 and a beta of 3.68. The firm’s 50-day simple moving average is $310.54 and its 200 day simple moving average is $302.78. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the firm posted $0.44 EPS. The firm’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts predict that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ALAB shares. UBS Group reiterated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Jefferies Financial Group raised their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Royal Bank Of Canada raised their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Barclays upped their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Eleven equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $340.79.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.